Assure Holdings Corp

Assure Holdings Corp. is a provider of outsourced intraoperative neuromonitoring and remote neurology services. The company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic, and ear, nose, and throat surgeries. The firm employs trained technologists that provide a direct point of contact in the operating room. Its physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure, communicating in real-time with the surgeon and technologist. The company was founded by Preston Thomas Parsons on May 24, 2017 and is headquartered in Englewood, CO.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Assure Holdings Corp. is a provider of outsourced intraoperative neuromonitoring and remote neurology services. The company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic, and ear, nose, and throat surgeries. The firm employs trained technologists that provide a direct point of contact in the operating room. Its physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure, communicating in real-time with the surgeon and technologist. The company was founded by Preston Thomas Parsons in 2016 and is headquartered in Denver, CO.

DENVER, June 27, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it has signed a Diagnostics Services Agreement with Neurovative Diagnostics, LLC (“Neurovative Diagnostics”), a global leader in the neurodiagnostic field. The agreement enables the Company to expand its offerings in the field of neurology to include electroencephalogram (“EEG”) testing.

Assure Holdings Expands Service Offerings to Address the High Growth EEG Services Market

DENVER, June 26, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it has signed a Letter of Intent (“LOI”) to purchase certain assets of Innovation Neuromonitoring, LLC (“Innovation”) for approximately $1.2 million in a cash and equity transaction. Established in 2016, Innovation is a leading IONM company primarily serving the Greater Dallas, Texas and Charleston, South Carolina regions.

Assure Holdings Signs Letter of Intent to Purchase Certain Assets of Innovation Neuromonitoring, LLC

DENVER, June 01, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced management will be presenting at upcoming conferences in June:

Assure Holdings to Present at Upcoming Conferences

Assure Holdings Corp. (NASDAQ:IONM ) Q1 2023 Earnings Conference Call May 16, 2023 4:30 PM ET Company Participants Brett Maas - Investor Relations John Farlinger - Director, Executive Chairman, Chief Executive Officer John Price - Chief Financial Officer Conference Call Participants Operator Greetings. Welcome to the Assure Holdings First Quarter 2023 Conference Call.

Assure Holdings Corp. (IONM) Q1 2023 Earnings Call Transcript

DENVER, May 16, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (NASDAQ: IONM) (“Assure Holdings” or the “Company”), a provider of intraoperative neuromonitoring and remote neurology services, today announced the closing of an underwritten public offering of 5,000,000 shares of its common stock (or prefunded warrants in lieu thereof) at an offering price to the public of $1.20 per share (or $1.199 per pre-funded warrant). The pre-funded warrants are immediately exercisable at a nominal exercise price of $0.001 or on a cashless basis and may be exercised at any time until all of the pre-funded warrants are exercised in full.

Assure Holdings Corp. Announces Closing Of $6 Million Underwritten Public Offering

DENVER, May 12, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, will hold a conference call on Tuesday, May 16, 2023 at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2023.

Assure Holdings Sets First Quarter 2023 Conference Call for Tuesday, May 16, 2023, at 4:30 p.m. ET

Assure (NASDAQ: IONM ) stock is falling on Friday after the medical company released preliminary earnings for the first quarter of 2023. That earnings report starts off badly with the company announcing preliminary diluted earnings per share of -$4.09.

Why Is Assure (IONM) Stock Down 36% Today?

DENVER, May 12, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (NASDAQ: IONM) (“Assure Holdings” or the “Company”), a provider of intraoperative neuromonitoring and remote neurology services, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock (or pre-funded warrants in lieu thereof) at an offering price to the public of $1.20 per share (or $1.199 per pre-funded warrant). The pre-funded warrants will be immediately exercisable at a nominal exercise price of $0.001 or on a cashless basis and may be exercised at any time until all of the pre-funded warrants are exercised in full. The closing of the offering is expected to occur on or about May 16, 2023, subject to the satisfaction of customary closing conditions.

Assure Holdings Corp. Announces Pricing of $6 Million Underwritten Public Offering

DENVER, May 10, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today reported its preliminary financial results for the first quarter ended March 31, 2023.

Assure Holdings Reports Preliminary First Quarter 2023 Financial Results

Expects $3.3 Million Federal Tax Refund for Employee Retention Credit (ERC) Multi-Million Dollar Reimbursement Lawsuit Set for Jury Trial in July DENVER, May 08, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today provided a corporate update related to its expectations for cash proceeds from a federal tax credit and a pending lawsuit. The Company is filing for the Employee Retention Credit (ERC), a refundable tax credit for businesses that continued to pay employees while shut down due to the COVID-19 pandemic.

Assure Holdings Provides Corporate Update

DENVER, May 05, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (Nasdaq: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it has expanded its operations and performed its first neuromonitoring case in the state of Montana. The first case was performed pursuant to a relationship established between Assure and a distinguished surgical center in Montana.

Assure Holdings Expands to New Market

Assure Holdings Corp. (NASDAQ:IONM ) Q4 2022 Earnings Conference Call April 3, 2023 9:00 AM ET Company Participants John Farlinger - Executive Chairman & CEO John Price – CFO Brett Maas - IR Conference Call Participants Jim Sidoti - Sidoti & Company Bill Sutherland - The Benchmark Company Operator Good day, everyone, and welcome to the Assure Holdings Fourth Quarter and Full Year 2022 Earnings Call. At this time, all participants are in a listen-only mode.

Assure Holdings Corp. (IONM) Q4 2022 Earnings Call Transcript

DENVER, April 03, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today reported financial results for the full year ended December 31, 2022.

Assure Holdings Reports 2022 Year End Financial Results

DENVER, March 31, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, will hold a conference call on Monday, April 3, 2023 at 9:00 a.m. Eastern Time to discuss its financial results for the fourth quarter and year ended December 31, 2022.

Assure Holdings Sets Fourth Quarter and Year End 2022 Conference Call for Monday, April 3, 2023, at 9:00 a.m. ET

DENVER, March 24, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that the company has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that it has regained compliance with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2) and currently meets all other applicable criteria for continued listing.

Assure Holdings Regains Compliance with NASDAQ Continued Listing Requirements

DENVER, March 03, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it effected a reverse stock split (the “Reverse Stock Split”) of its shares of common stock, $0.001 par value, at a ratio of 20 (old) for 1 (new) that will become effective on March 4, 2023 at 12:01 a.m. Pacific Standard Time.

Assure Announces Reverse Stock Split

DENVER, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, has been invited to present at the Third Annual Winter Wonderland – Best Ideas Virtual Investor conference, which is being held virtually on February 21st – 24th, 2023. John Price, Assure's Chief Financial Officer, will be presenting.

As a reminder, Assure Holdings to Present at Third Annual Winter Wonderland – Best Ideas Virtual Investor Conference on February 21

DENVER, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced a cost reduction plan (the “Plan") intended to accelerate its path to EBITDA profitability and positive operating cash flow.

Assure Holdings Announces Cost Reduction Plan to Accelerate Path to Profitability

DENVER, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, is pleased to announce that on December 31, 2022, it completed the acquisition (the “Acquisition”) of substantially all of the assets of Neuroprotect Neuromonitoring, LLC, and certain of its affiliated entities (collectively, “NervePro”), a Colorado-based IONM service provider owned by J. Paul Elliott, M.D. of the Colorado Brain & Spine Institute (“CBSI”). Assure acquired specifically, accounts receivable for services after December 1, 2022, as well as NervePro's material contracts, business relationships and other tangible assets.

Assure Holdings Announces Acquisition of NervePro

DENVER, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that it held its annual general meeting of shareholders on December 28, 2022 (the “Meeting”) and that all matters submitted to the shareholders of the Company for approval as set out in the Company's definitive proxy statement dated December 2, 2022 (the “Proxy Statement”), were approved by the requisite majority of votes cast at the Meeting, including:

Assure Holdings Announces Results of Annual General Meeting of Shareholders

DENVER, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced that management will participate in the following investor conferences in December 2022:

Assure to Attend Investor Conferences in December 2022

Assure Holdings Corp. (NASDAQ:IONM ) Q3 2022 Results Conference Call November 14, 2022 4:30 PM ET Company Participants Scott Kozak - Director of Investor Relations John Farlinger - Executive Chairman & Chief Executive Officer John Price - Chief Financial Officer Conference Call Participants Jim Sidoti - Sidoti and Company Bill Sutherland - Benchmark Company Operator Good day, everyone, and welcome to the Assure Holdings Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.

Assure Holdings Corp. (IONM) Q3 2022 Earnings Call Transcript

Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -28.57% and 17.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Assure Holdings Corp. (IONM) Reports Q3 Loss, Lags Revenue Estimates

DENVER, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today reported financial results for the third quarter ended September 30, 2022.

Assure Holdings Reports Third Quarter 2022 Financial Results

DENVER, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that shareholders of record as of the close of business on November 18, 2022, will be entitled to notice of, and to vote at, the Annual Meeting of Shareholders to be held on December 28, 2022. The Company anticipates that the notice of the Annual Meeting of Shareholders will be mailed to shareholders on or about November 28, 2022.

News for Assure Holdings Corp Stock (IONM)